DKSH Holding AG (DKSH.SW) fair value

ACCE thesis

DKSH runs market-expansion services for consumer, healthcare and performance-materials brands in Asia, handling import registration, distribution, marketing and after-sales for clients entering or scaling in the region. Its moat is the breadth of its footprint and the regulatory and logistics know-how that comes with operating across many Asian markets, which makes it hard for a brand to replicate that reach on its own. Revenue fell 0.9% in the latest period, and the 2.8% operating margin on a 7.9% gross margin shows how thin the service spread is, so any recovery in volumes or mix shows up quickly in profit. The stock trades at 18.8x forward earnings against 23.4x trailing, which implies consensus expects earnings to rise, and a 12.6% ROE says the business still earns a respectable return on its equity base. The thesis rests on whether top-line growth returns to positive territory; a flat or declining top line with this margin profile leaves little room for error, so the case warrants a deeper look at margin trajectory and segment-level growth before any conclusion.